يعرض 1 - 10 نتائج من 13 نتيجة بحث عن '"Elisabetta Botti"', وقت الاستعلام: 1.12s تنقيح النتائج
  1. 1

    المصدر: Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
    Scientific Reports, Vol. 10, No 1 (2020) P. 5851
    Scientific Reports
    Scientific reports, vol. 10, no. 1, pp. 5851

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية
  3. 3

    المصدر: Nature Communications, Vol. 10, No 1 (2019) P. 1731
    Nature Communications, Vol 10, Iss 1, Pp 1-14 (2019)

    مصطلحات موضوعية: 0301 basic medicine, Male, Chemokine, Biopsy, Systemic/immunology/microbiology/pathology, General Physics and Astronomy, 02 engineering and technology, Plasmacytoid dendritic cell, ddc:616.07, CXCR3, Platelet Factor 4, Scleroderma, Interferon, immune system diseases, Receptors, lcsh:Science, skin and connective tissue diseases, CXCR3/immunology/metabolism, Skin, ddc:616, Bacterial/immunology/metabolism, Settore MED/35 - Malattie Cutanee e Veneree, Multidisciplinary, biology, integumentary system, Chemistry, hemic and immune systems, Middle Aged, 021001 nanoscience & nanotechnology, Skin/cytology/immunology/microbiology/pathology, Healthy Volunteers, Liquid Crystals, Adult, aged, biopsy, case-control studies, DNA, bacterial, dendritic cells, female, healthy volunteers, humans, interferon-alpha, liquid crystals, male, middle aged, platelet factor 4, receptors, CXCR3, scleroderma, systemic, skin, toll-like receptor 9, Interferon-alpha/immunology/metabolism, Female, Signal transduction, 0210 nano-technology, Toll-Like Receptor 9/immunology/metabolism, medicine.drug, DNA, Bacterial, Adult, Receptors, CXCR3, Science, chemical and pharmacologic phenomena, General Biochemistry, Genetics and Molecular Biology, Dendritic Cells/immunology/metabolism, 03 medical and health sciences, Immune system, stomatognathic system, medicine, Humans, Platelet Factor 4/immunology/metabolism, Aged, Innate immune system, Scleroderma, Systemic, TLR9, Interferon-alpha, General Chemistry, Dendritic Cells, DNA, stomatognathic diseases, 030104 developmental biology, Toll-Like Receptor 9, Case-Control Studies, Cancer research, biology.protein, lcsh:Q

  4. 4

    المساهمون: Chimenti, Maria Sole, Sunzini, Flavia, Fiorucci, Laura, Botti, Elisabetta, Fonti, Giulia Lavinia, Conigliaro, Paola, Triggianese, Paola, Costa, Luisa, Caso, Francesco, Giunta, Alessandro, Esposito, Maria, Bianchi, Luca, Santucci, Roberto, Perricone, Roberto

    المصدر: Frontiers in Immunology, Vol 9 (2018)
    Frontiers in Immunology

  5. 5

    المصدر: Frontiers in Immunology
    Frontiers in Immunology, Vol 9 (2018)

  6. 6
  7. 7

    المساهمون: Cesarini, V, Guida, E, Todaro, F, Di Agostino, S, Tassinari, V, Nicolis, S, Favaro, R, Caporali, S, Lacal, P, Botti, E, Costanzo, A, Rossi, P, Jannini, E, Dolci, S

    المصدر: Oncogene (Basingstoke) 36 (2017): 4508–4515. doi:10.1038/onc.2017.53
    info:cnr-pdr/source/autori:Cesarini, V.; Guida, E.; Todaro, F.; Di Agostino, S.; Tassinari, V.; Nicolis, S.; Favaro, R.; Caporali, S.; Lacal, P. M.; Botti, E.; Costanzo, A.; Rossi, P.; Jannini, E. A.; Dolci, S./titolo:Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo/doi:10.1038%2Fonc.2017.53/rivista:Oncogene (Basingstoke)/anno:2017/pagina_da:4508/pagina_a:4515/intervallo_pagine:4508–4515/volume:36

  8. 8
  9. 9

    مصطلحات موضوعية: Keratinocytes, Chemokine, medicine.medical_treatment, T-Lymphocytes, Population, Anti-Inflammatory Agents, Pharmaceutical Science, Inflammation, antagonists /&/ inhibitors/genetics/immunology, Antibodies, Pathogenesis, Psoriasis, Monoclonal, medicine, Animals, Humans, Innate, genetics, drug effects/immunology, education, Animals, Anti-Inflammatory Agents, administration /&/ dosage/adverse effects/therapeutic use, Antibodies, administration /&/ dosage/adverse effects/therapeutic use, Dendritic Cells, drug effects/immunology, Humans, Immunity, genetics, Immunosuppressive Agents, administration /&/ dosage/adverse effects/therapeutic use, Interleukins, antagonists /&/ inhibitors/genetics/immunology, Keratinocytes, drug effects/immunology, Psoriasis, drug therapy/genetics/immunology, T-Lymphocytes, Settore MED/35 - Malattie Cutanee e Veneree, Settore MED/12 - Gastroenterologia, education.field_of_study, Innate immune system, administration /&/ dosage/adverse effects/therapeutic use, integumentary system, biology, business.industry, Interleukins, Immunity, Antibodies, Monoclonal, antibodies, monoclonal, anti-inflammatory agents, dendritic cells, animals, psoriasis, humans, interleukins, immunity, innate, keratinocytes, immunosuppressive agents, t-lymphocytes, Dendritic Cells, Acquired immune system, medicine.disease, Immunity, Innate, Cytokine, Immunology, biology.protein, drug therapy/genetics/immunology, medicine.symptom, business, Immunosuppressive Agents, Biotechnology

  10. 10

    المصدر: Proceedings of the National Academy of Sciences of the United States of America 108 (2011): 13710–13715. doi:10.1073/pnas.1110931108
    info:cnr-pdr/source/autori:Botti, Elisabetta; Spallone, Giulia; Moretti, Francesca; Marinari, Barbara; Pinetti, Valentina; Galanti, Sergio; De Meo, Paolo D Onorio; De Nicola, Francesca; Ganci, Federica; Castrignanò, Tiziana; Pesole, Graziano; Chimenti, Sergio; Guerrini, Luisa; Fanciulli, Maurizio; Blandino, Giovanni; Karin, Michael; Costanzo, Antonio/titolo:Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas/doi:10.1073%2Fpnas.1110931108/rivista:Proceedings of the National Academy of Sciences of the United States of America/anno:2011/pagina_da:13710/pagina_a:13715/intervallo_pagine:13710–13715/volume:108